Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Acromegaly: full-pipeline trial registry
4 of 14 indexed Acromegaly trials are currently recruiting.
Corpus placement: #1,230 of 28,707 conditions by registered trial count.
14 US clinical trials · 4 currently recruiting · #1,230 of 28,707 conditions by registered trial count
Acromegaly: 14 US clinical trials tracked, 4 recruiting.
Acromegaly is the subject of 14 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 5 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Crinetics Pharmaceuticals, running 3 of these trials.
Enrollment posture brief
Registry condition acromegaly
OPEN 4 | RECR 29% | LATE 5 | EARLY 4 | RANK #1230 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Acne Scars (29% recruiting · 7 trials)
Acromegaly lists 4 open slots (29% of 14 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Acromegaly on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Acromegaly is recruiting below its size-band peers.
4 of 14 indexed trials (28.6%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Acromegaly research.
Crinetics Pharmaceuticals accounts for 3 of 14 trials (21.4%). 10 distinct sponsors appear on at least one study for this condition label.
-
Most Acromegaly trials plan to enrol fewer than 100 people.
Median target enrolment is 72 among the 14 trials that report a genuine target (sentinel values excluded). 10 of those (71.4%) plan for fewer than 100 participants.
-
Acromegaly research is mostly interventional.
11 interventional and 3 observational studies make up this index (78.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
14 total, page 1 of 1
A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs
Debiopharm International
NCT06930625
ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly
Alexion Pharmaceuticals
NCT07037420
Study of MAR002 in Healthy Men
Marea Therapeutics
NCT07195175
Diet in the Management of Acromegaly
Cedars-Sinai Medical Center
NCT05401084
A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (PATHFNDR-2)
Crinetics Pharmaceuticals
NCT05192382
A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly
Crinetics Pharmaceuticals
NCT04837040
A Study to Evaluate the Long-Term Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Advance)
Crinetics Pharmaceuticals
NCT04261712
Peri-operative Dynamics of the Growth Hormone Axis in Subjects With Acromegaly
Cedars-Sinai Medical Center
NCT00921609
Treatment Patterns and Treatment Outcomes for Acromegaly
Columbia University
NCT03043586
A Study To Compare The Efficacy And Safety Of Pegvisomant To That Of Sandostatin Lar Depot In Patients With Acromegaly
Pfizer
NCT00068042
Bone MicroArchitecture in Acromegaly
Columbia University
NCT03225040
Effects of Growth Hormone Administration on Cardiovascular Risk in Cured Acromegalics With Growth Hormone Deficiency
Massachusetts General Hospital
NCT00182091
A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly
Camurus AB
NCT04076462
Sandostatin LAR Depot vs. Surgery for Treating Acromegaly
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT00001860
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 3 |
| Phase 3 | 4 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Acromegaly records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Acromegaly trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Acromegaly page
14 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Acromegaly trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Crinetics Pharmaceuticals sponsors the most Acromegaly trials on record, review their full trial history before evaluating a specific study. See Crinetics Pharmaceuticals's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Acromegaly condition card totals 14 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.